Clinical Trials for Advanced Solid Tumor

Find clinical trials for advanced solid tumor. Discover research opportunities and treatment options in your area.

362 Active Trials Found

Showing 362 trials on this page

Page 5 of 19

Study of SGN1 in Patients With Advanced Solid Tumor

NCT ID: NCT05038150

This clinical trial is studying a new treatment called SGN1 for patients with advanced solid tumors that have not responded to standard therapies. SGN1 works by targeting tumors that depend on a sp...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Taichung City, , Taiwan +10 more

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

NCT ID: NCT05103345

This clinical trial is studying a treatment called SGN1, which is injected directly into tumors in patients with advanced solid tumors that have not responded to standard treatments. The main goals...

Recruiting

Phase: PHASE1 Type: interventional Locations: Taichung, , Taiwan, Chengdu, Sichuan, China +7 more

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

NCT ID: NCT06959615

This clinical trial is studying a new treatment called JAB-23E73 for patients with advanced solid tumors that have changes in the KRAS gene, which can make cancer harder to treat. The goal is to un...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China, Beijing, Beijing, China +2 more

KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II

NCT ID: NCT05525858

The KPMNG Study is looking at a new way to treat advanced solid tumors, which are types of cancer that have spread and are difficult to treat. This trial will help doctors understand how to use gen...

Recruiting

Type: observational Locations: Seongnam, , Korea, Republic Of, Seoul, , Korea, Republic Of +36 more

First in Human Study of T3P-Y058-739 (T3P)

NCT ID: NCT05120596

This clinical trial, titled "First in Human Study of T3P-Y058-739 (T3P)," is exploring a new treatment for patients with advanced solid tumors that cannot be surgically removed and have no other ef...

Recruiting

Phase: PHASE1 Type: interventional Locations: Madrid, , Spain, Madrid, , Spain +10 more

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

NCT ID: NCT06859762

This clinical trial is looking at a new treatment called YL217 for patients with advanced solid tumors, which are types of cancer that form in solid organs like the stomach, pancreas, or intestines...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, New Haven, Connecticut, United States +2 more

A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors

NCT ID: NCT06669975

This clinical trial is studying a new treatment called AP402 for patients with advanced solid tumors that are HER2-positive, meaning their cancer cells have a specific protein that can promote grow...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bedford Park, South Australia, Australia, Perth, Western Australia, Australia +1 more

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

NCT ID: NCT06953323

This clinical trial is studying a new treatment called WJB001, which is being tested in combination with other cancer therapies for patients with advanced solid tumors. The main goal is to find out...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China, Wuhan, , China +8 more

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

NCT ID: NCT06130254

This clinical trial is testing a new combination of two investigational drugs, adagrasib and olaparib, to see if they are safe and how well they work for patients with advanced solid tumors that ha...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Clinical Studies for the Treatment of Advanced Solid Tumors

NCT ID: NCT06825494

This clinical trial is investigating a new treatment, LM-108, for people with advanced solid tumors, which are abnormal growths of tissue that are difficult to treat. The study is in its early phas...

Recruiting

Phase: PHASE1 Type: interventional Locations: Changsha, Hunan, China, Shanghai, Shanghai, China +27 more

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

NCT ID: NCT05585320

This clinical trial is studying a new treatment called IMM-1-104 for patients with specific types of advanced or metastatic solid tumors, particularly those with mutations in a gene called RAS. The...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Rochester, Minnesota, United States +20 more

A Study of DS-1471a In Subjects With Advanced Solid Tumors

NCT ID: NCT06074705

This clinical trial is studying a new treatment called DS-1471a for adults with advanced solid tumors, which are types of cancer that have spread or cannot be surgically removed. The main goals of ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States, Tokyo, , Japan +3 more

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

NCT ID: NCT06937970

This clinical trial is studying a new treatment called MRTX1719 for patients with advanced solid tumors that have a specific genetic change known as the homozygous deletion of the MTAP gene. The ty...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States, Rochester, Minnesota, United States +22 more

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

NCT ID: NCT06253130

This clinical trial is testing a new medication called IMP1734, which is designed to help patients with advanced solid tumors, specifically those with recurrent breast cancer, ovarian cancer, or me...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, Woolloongabba, Queensland, Australia +22 more

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT ID: NCT06586957

This clinical trial is studying a new treatment called NKT3964 for adults with advanced or metastatic solid tumors, which are cancers that have spread beyond their original location. The trial aims...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Nashville, Tennessee, United States +6 more

Phase I Study of HS-20108 in Participants With Advanced Solid Tumors

NCT ID: NCT06936735

This clinical trial is studying a new treatment called HS-20108 for patients with advanced solid tumors, which are types of cancer that form solid masses, like in the breast, lung, or colon. The ma...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Jilin, Jilin, China

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

NCT ID: NCT06938880

This clinical trial is investigating a new treatment approach for patients with advanced solid tumors, which are cancers that form in solid organs like the lungs, liver, or cervix. The study will l...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

NCT ID: NCT06540066

This clinical trial is studying a new treatment called BGB-B3227, which is an antibody designed to target certain types of advanced or metastatic solid tumors, such as advanced cancer that has spre...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milano, , Italy, Hackensack, New Jersey, United States +15 more

A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors

NCT ID: NCT06244485

This clinical trial is studying a new treatment called valemetostat tosylate combined with DXd ADCs for patients with advanced solid tumors, which are cancers that have spread and cannot be easily ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States, San Diego, California, United States +33 more

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

NCT ID: NCT05279300

This clinical trial is studying a new experimental drug called CS5001 to see how safe it is and whether it can help patients with advanced solid tumors and lymphomas. This is the first time this dr...

Recruiting

Phase: PHASE1 Type: interventional Locations: East Setauket, New York, United States, Shanghai, , China +36 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions